From the SUNY Downstate Health Sciences University, Brooklyn, New York (M.M.P.); Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New York, New York (H.E.M.-M.); Icahn School of Medicine at Mount Sinai, New York, New York (M.F.L.-W.); Maimonides Medical Center, Brooklyn, New York (M.F.L.-W.); Burn Pits 360 Veterans Organization, Robstown, Texas (J.M.T.); Henry Mayo Newhall Hospital, Valencia, California (E.F); Hematology and Oncology Section, Minneapolis VA Health Care System, Minneapolis, Minnesota (M.A.K.); Department of Medicine, University of Minnesota, Minneapolis, Minnesota (M.A.K.); Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota (M.A.K., J.H.T.); Minneapolis VA Health Care System, Minneapolis, Minnesota (J.H.T., T.A.B.); Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota (J.H.T.); Department of Food Science and Nutrition, University of Minnesota, St Paul, Minnesota (T.A.B.); Department of Neuroscience, University of Minnesota, Minneapolis, Minnesota (T.A.B.); Center for Veterans Research and Education, Minneapolis, Minnesota (T.A.B., A.G.); Drexel University College of Medicine, Philadelphia, Pennsylvania (R.A.P.); Stony Brook University School of Nursing and Stony Brook University Cancer Center, Stony Brook, New York (P.K.G.); Thomas Jefferson University School of Medicine, Philadelphia, Pennsylvania (P.B.); Division of Pulmonary and Critical Care, Division of Allergy/Immunology, Department of Medicine, Department of Occupational Medicine, Epidemiology and Prevention, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, Northwell Health, New Hyde Park, New York (A.M.S.); Department of Occupational Medicine, Epidemiology and Prevention, International Center of Excellence in Deployment Health and Medical Geosciences, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York (A.M.S.); Stony Brook University, Department of Technology and Society, College of Engineering and Applied Sciences, Stony Brook, New York (A.M.S.); Three Village Allergy and Asthma, PLLC, South Setauket, New York (A.M.S.); and RDS2 Solutions, Inc, Stony Brook, New York (A.M.S.).
J Occup Environ Med. 2023 Sep 1;65(9):740-744. doi: 10.1097/JOM.0000000000002919. Epub 2023 Jun 24.
The aim of the study is to describe rates of hematuria and other lower urinary tract symptoms, including self-reported cancer rates, among veterans postburn pits emissions exposure during deployment to Iraq and Afghanistan.
US post-9/11 veterans with burn pits emissions exposure confirmed via DD214 forms in the Burn Pits360.org Registry were sent a modified survey. Data were deidentified and anonymously coded.
Twenty-nine percent of the 155 respondents exposed to burn pits self-reported seeing blood in their urine. The average index score of our modified American Urological Association Symptom Index Survey was 12.25 (SD, 7.48). High rates of urinary frequency (84%) and urgency (76%) were self-reported. Bladder, kidney, or lung cancers were self-reported in 3.87%.
US veterans exposed to burn pits are self-reporting hematuria and other lower urinary tract symptoms.
本研究旨在描述在伊拉克和阿富汗部署期间接触过战后坑排放物的退伍军人血尿和其他下尿路症状（包括自我报告的癌症发病率）的发生率。
通过 Burn Pits360.org 注册表中的 DD214 表格确认接触过战后坑排放物的美国 9/11 后退伍军人收到了经过修改的调查。数据被去识别和匿名编码。
在 155 名接受过战后坑排放物暴露的受访者中，有 29%的人自我报告尿液中有血。我们修改后的美国泌尿协会症状指数调查的平均指数评分为 12.25（标准差，7.48）。自我报告的尿频率（84%）和紧迫性（76%）较高。自我报告的膀胱癌、肾癌或肺癌发生率为 3.87%。
接触过战后坑排放物的美国退伍军人自我报告血尿和其他下尿路症状。
